Isselbacher EM, Preventza O, Hamilton Black J 3rd, Augoustides JG, Beck AW, Bolen MA, Braverman AC, Bray BE, Brown-Zimmerman MM, Chen EP, Collins TJ, DeAnda A Jr, Fanola CL, Girardi LN, Hicks CW, Hui DS, Schuyler Jones W, Kalahasti V, Kim KM, Milewicz DM, Oderich GS, Ogbechie L, Promes SB, Gyang Ross E, Schermerhorn ML, Singleton Times S, Tseng EE, Wang GJ, Woo YJ. 2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation. 2022 Dec 13;146(24):e334-e482. doi: 10.1161/CIR.0000000000001106. Epub 2022 Nov 2. PMID: 36322642; PMCID: PMC9876736. Available From: https://ccevent.site/wp-content/uploads/2023/08/60-1-Gap-article-2-2022-ACC-AHA-Guideline-for-the-Diagnosis-and-Management-of-aortic-disease.docx
Mathur A, Mohan V, Ameta D, Gaurav B, Haranahalli P. Aortic aneurysm. J Transl Int Med. 2016 Apr 1;4(1):35-41. doi: 10.1515/jtim-2016-0008. Epub 2016 Apr 14. PMID: 28191516; PMCID: PMC5290913.
Davis FM, Daugherty A, Lu HS. Updates of Recent Aortic Aneurysm Research. Arterioscler Thromb Vasc Biol. 2019 Mar;39(3):e83-e90. doi: 10.1161/ATVBAHA.119.312000. PMID: 30811252; PMCID: PMC6394847.
Al-Abcha A, Saleh Y, Mujer M, Boumegouas M, Herzallah K, Charles L, Elkhatib L, Abdelkarim O, Kehdi M, Abela GS. Meta-analysis Examining the Usefulness of Angiotensin Receptor blockers for the Prevention of Aortic Root Dilation in Patients With the Marfan Syndrome. Am J Cardiol. 2020 Aug 1;128:101-106. doi: 10.1016/j.amjcard.2020.04.034. Epub 2020 May 19. PMID: 32650901. Available From: https://ccevent.site/wp-content/uploads/2023/09/ARB-MFS-AJC-2020.pdf
Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines [published correction appears in Circulation. 2021 Feb 2;143(5):e228] [published correction appears in Circulation. 2021 Mar 9;143(10):e784]. Circulation. 2021;143(5):e35-e71. doi:10.1161/CIR.0000000000000932. Available From: https://ccevent.site/wp-content/uploads/2023/08/60-Gap-article-3-ACC-AHA-Guideline-for-the-Management-of-Patients-with-Valvular-Heart-Disease.pdf
Aluru JS, Barsouk A, Saginala K, Rawla P, Barsouk A. Valvular Heart Disease Epidemiology. Med Sci (Basel). 2022 Jun 15;10(2):32. doi: 10.3390/medsci10020032. PMID: 35736352; PMCID: PMC9228968.
Puri R, Dykun I, Kalra A. The Spectrum of Valvular Heart Disease and the Importance of “Mild”. JAMA Netw Open. 2022;5(5):e2211955. doi:10.1001/jamanetworkopen.2022.11955
Mehta L, Warnes C, Bradley E, Burton T, Economy K, Mehran R, Safdar B, Sharma G, Wood M, Valente AM, Santos Volgman A. Cardiovascular Considerations in Caring for Pregnant Patients. A Scientific Statement from the American Heart Association. Available from: https://ccevent.site/wp-content/uploads/2023/09/Cardiac-Considerations-in-the-Pregnant-patient.pdf
Grodzinsky A, Florio K, Spertus JA, Daming T, Lee J, Rader V, Nelson L, Gray R, White D, Swearingen K, Thomas M, Singh A, Magalski A, Schmidt L. Importance of the Cardio-Obstetrics Team. Curr Treat Options Cardiovasc Med. 2019 Dec 10;21(12):84. doi: 10.1007/s11936-019-0789-1. PMID: 31820201. Available from: https://ccevent.site/wp-content/uploads/2023/08/60-1-Gap-article-1-Importance-of-Cardio-Obstetrics-Team.pdf
Khalid H, Karishma F, Mumtaz H, Saqib M, Iftikhar M, Shahab R. Current status and future of cardio-obstetrics-review. Ann Med Surg (Lond). 2023 May 3;85(6):2774-2780. doi: 10.1097/MS9.0000000000000773. PMID: 37363552; PMCID: PMC10289498.
Graves CR, Woldemichael RM, Davis SF. Cardio-Obstetrics: Moving Beyond Programming to Action. J Am Heart Assoc. 2023 Mar 7;12(5):e028141. doi: 10.1161/JAHA.122.028141. Epub 2023 Feb 27. PMID: 36847170; PMCID: PMC10111467.
Spertus JA, Fine JT, Elliott P, Ho CY, Olivotto I, Saberi S, Li W, Dolan C, Reaney M, Sehnert AJ, Jacoby D. Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): health status analysis of a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2021 Jun 26;397(10293):2467-2475. doi: 10.1016/S0140-6736(21)00763-7. Epub 2021 May 15. PMID: 34004177. Available From: https://ccevent.site/wp-content/uploads/2023/08/60-Gap-article-4-Mavacamten-for-treatment-of-symptomatic-obstructive-hypertrophic-cardiomyopathy.pdf
Basit H, Brito D, Sharma S. Hypertrophic Cardiomyopathy. [Updated 2023 Apr 7]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK430788/
Maron BJ, Desai MY, Nishimura RA, Spirito P, Rakowski H, Towbin JA, Rowin EJ, Maron MS, Sherrid MV. Diagnosis and Evaluation of Hypertrophic Cardiomyopathy: JACC State-of-the-Art Review. J Am Coll Cardiol. 2022 Feb 1;79(4):372-389. doi: 10.1016/j.jacc.2021.12.002. PMID: 35086660.
